Novartis AG (NYSE: NVS) completed its acquisition of Avidity Biosciences, Inc., making the company a wholly owned subsidiary. The transaction ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE